Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / S&P PHARMAC
-
Total 13F shares
-
2,870,725
-
Share change
-
-60,890
-
Total reported value
-
$116,517,745
-
Put/Call ratio
-
144%
-
Price per share
-
$40.58
-
Number of holders
-
65
-
Value change
-
-$2,569,356
-
Number of buys
-
21
-
Number of sells
-
33
Institutional Holders of SPDR SERIES TRUST - S&P PHARMAC (XPH) as of Q2 2025
As of 30 Jun 2025,
SPDR SERIES TRUST - S&P PHARMAC (XPH) was held by
65 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,870,725 shares.
The largest 10 holders included
BANK OF AMERICA CORP /DE/, MORGAN STANLEY, CITIGROUP INC, Kingsview Wealth Management, LLC, FIRST CITIZENS BANK & TRUST CO, Envestnet Portfolio Solutions, Inc., GOLDMAN SACHS GROUP INC, LPL Financial LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and WELLS FARGO & COMPANY/MN.
This page lists
65
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.